Compliance program

Introduction

General

Novartis Vaccines and Diagnostics, Inc. ("Novartis V&D") is committed to establishing and maintaining an effective Integrity and Compliance Program in accordance with "Compliance Program Guidance for Pharmaceutical Manufacturers," published by the Office of Inspector General, U.S. Department of Health and Human Services (the "HHS-OIG Guidance"). Our Integrity and Compliance Program is one of the key components of our commitment to the highest standards of corporate conduct.

Purpose

The purpose of our Integrity and Compliance Program is to prevent and detect violations of law or company policies. As the HHS-OIG Guidance recognizes, however, the implementation of such a program cannot guarantee that improper employee conduct will be entirely eliminated. Nonetheless, it is our expectation that employees will comply with our Code of Conduct, and the policies established in support of such a Code. In the event that we become aware of violations of law or company policy, we will investigate the matter and, where appropriate, take disciplinary action and implement corrective measures to prevent future violations.

View our compliance declaration
(20 KB)

View our employee code of conduct
(50 KB)

View our corporate citizenship policy on our commitment to ethical conduct
(20 KB)

Described below are the fundamental elements of the Novartis V&D Integrity and Compliance Program. As HHS-OIG calls for in its Guidance, we have tailored our program to fit the unique environment of our company. Moreover, our Integrity and Compliance Program is dynamic; we regularly review and enhance our program to meet our evolving compliance needs.

Contact information

For questions or comments regarding Novartis Vaccines and Diagnostics Integrity and Compliance Program, or to request printed copies of selected Integrity and Compliance Program materials, please contact us.

1-617-871-7982

1-617-871-8167

1-617-871-8911

nvd.integritycompliance@novartis.com

Revision date 25 May 2011